China Endometriosis Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.

    This report elaborates on the current development of the Endometriosis industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bayer HealthCare

    • Pfizer

    • EndoCeutics

    • Astellas Pharma

    • Forendo Pharma

    • Kissei Pharmaceutical

    • Debiopharm

    • Addex Therapeutics

    • AbbVie

    • Takeda

    • Euroscreen

    • Neurocrine Biosciences

    By Type:

    • Oral Contraceptive Pills

    • Gonadotropins Releasing Hormone Agonists

    • Non-Steroidal Anti-Inflammatory Drugs

    • Progestin

    By Application:

    • E-commerce

    • Pharmacies

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Endometriosis Market Overview 2018-2029

    • 1.1 China Endometriosis Industry Development Overview

    • 1.2 China Endometriosis Industry Development History

    • 1.3 China Endometriosis Industry Market Size (2018-2029)

    • 1.4 China Endometriosis Market Analysis by Type from Production Side

      • 1.4.1 China Endometriosis Production Volume, Production Value and Growth Rate of Oral Contraceptive Pills (2018-2029)

      • 1.4.2 China Endometriosis Production Volume, Production Value and Growth Rate of Gonadotropins Releasing Hormone Agonists (2018-2029)

      • 1.4.3 China Endometriosis Production Volume, Production Value and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2029)

      • 1.4.4 China Endometriosis Production Volume, Production Value and Growth Rate of Progestin (2018-2029)

    • 1.5 China Endometriosis Market Analysis by Application from Consumption End

      • 1.5.1 China Endometriosis Sales Volume, Sales Value and Growth Rate of E-commerce (2018-2029)

      • 1.5.2 China Endometriosis Sales Volume, Sales Value and Growth Rate of Pharmacies (2018-2029)

      • 1.5.3 China Endometriosis Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Endometriosis Market Analysis by Region

      • 1.6.1 North China Endometriosis Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Endometriosis Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Endometriosis Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Endometriosis Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Endometriosis Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Endometriosis Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Endometriosis Market Size and Growth Rate from 2018-2029

    Chapter 2 China Endometriosis Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Endometriosis Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Endometriosis Market Status and Competition Analysis in 2023

      • 2.2.3 China Endometriosis Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Endometriosis Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Endometriosis Industry Development

    Chapter 3 EndometriosisIndustry Chain Analysis

    • 3.1 Endometriosis Industry Chain

    • 3.2 Endometriosis Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Endometriosis Market

    • 3.3 Endometriosis Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Endometriosis Market

    Chapter 4 China Endometriosis Market, by Type

    • 4.1 China Endometriosis Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Endometriosis Total Production Volume and Growth Rate from Production Side

    • 4.5 China Endometriosis Production Volume and Growth Rate, by Type

      • 4.5.1 China Endometriosis Production Volume and Growth Rate of Oral Contraceptive Pills

      • 4.5.2 China Endometriosis Production Volume and Growth Rate of Gonadotropins Releasing Hormone Agonists

      • 4.5.3 China Endometriosis Production Volume and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs

      • 4.5.4 China Endometriosis Production Volume and Growth Rate of Progestin

    Chapter 5 China Endometriosis Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Endometriosis Total Market Size and Growth Rate from Consumption End

    • 5.5 China Endometriosis Market Size and Growth Rate, by Application

      • 5.5.1 China Endometriosis Market Size and Growth Rate of E-commerce

      • 5.5.2 China Endometriosis Market Size and Growth Rate of Pharmacies

      • 5.5.3 China Endometriosis Market Size and Growth Rate of Hospitals

    Chapter 6 China Endometriosis Market, by Region

    • 6.1 China Endometriosis Production Volume and Production Value, by Region

    • 6.2 China Endometriosis Sales Volume and Sales Value, by Region

    Chapter 7 North China Endometriosis Market Analysis

    • 7.1 North China Endometriosis Market, by Type

    • 7.2 North China Endometriosis Market, by Application

    Chapter 8 Central China Endometriosis Market Analysis

    • 8.1 Central China Endometriosis Market, by Type

    • 8.2 Central China Endometriosis Market, by Application

    Chapter 9 South China Endometriosis Market Analysis

    • 9.1 South China Endometriosis Market, by Type

    • 9.2 South China Endometriosis Market, by Application

    Chapter 10 East China Endometriosis Market Analysis

    • 10.1 East China Endometriosis Market, by Type

    • 10.2 East China Endometriosis Market, by Application

    Chapter 11 Northeast China Endometriosis Market Analysis

    • 11.1 Northeast China Endometriosis Market, by Type

    • 11.2 Northeast China Endometriosis Market, by Application

    Chapter 12 Southwest China Endometriosis Market Analysis

    • 12.1 Southwest China Endometriosis Market, by Type

    • 12.2 Southwest China Endometriosis Market, by Application

    Chapter 13 Northwest China Endometriosis Market Analysis

    • 13.1 Northwest China Endometriosis Market, by Type

    • 13.2 Northwest China Endometriosis Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bayer HealthCare

        • 14.1.1 Bayer HealthCare Company Profile

        • 14.1.2 Bayer HealthCare Endometriosis Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer

        • 14.2.1 Pfizer Company Profile

        • 14.2.2 Pfizer Endometriosis Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 EndoCeutics

        • 14.3.1 EndoCeutics Company Profile

        • 14.3.2 EndoCeutics Endometriosis Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Astellas Pharma

        • 14.4.1 Astellas Pharma Company Profile

        • 14.4.2 Astellas Pharma Endometriosis Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Forendo Pharma

        • 14.5.1 Forendo Pharma Company Profile

        • 14.5.2 Forendo Pharma Endometriosis Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Kissei Pharmaceutical

        • 14.6.1 Kissei Pharmaceutical Company Profile

        • 14.6.2 Kissei Pharmaceutical Endometriosis Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Debiopharm

        • 14.7.1 Debiopharm Company Profile

        • 14.7.2 Debiopharm Endometriosis Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Addex Therapeutics

        • 14.8.1 Addex Therapeutics Company Profile

        • 14.8.2 Addex Therapeutics Endometriosis Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 AbbVie

        • 14.9.1 AbbVie Company Profile

        • 14.9.2 AbbVie Endometriosis Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Takeda

        • 14.10.1 Takeda Company Profile

        • 14.10.2 Takeda Endometriosis Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Euroscreen

        • 14.11.1 Euroscreen Company Profile

        • 14.11.2 Euroscreen Endometriosis Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Neurocrine Biosciences

        • 14.12.1 Neurocrine Biosciences Company Profile

        • 14.12.2 Neurocrine Biosciences Endometriosis Market Performance

        • 14.12.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Endometriosis Industry Research Conclusions

    • 15.2 Endometriosis Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Endometriosis Industry Market Size (2018-2029)

    • Figure China Endometriosis Production Volume, Production Value and Growth Rate of Oral Contraceptive Pills (2018-2029)

    • Figure China Endometriosis Production Volume, Production Value and Growth Rate of Gonadotropins Releasing Hormone Agonists (2018-2029)

    • Figure China Endometriosis Production Volume, Production Value and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2029)

    • Figure China Endometriosis Production Volume, Production Value and Growth Rate of Progestin (2018-2029)

    • Figure China Endometriosis Sales Volume, Sales Value and Growth Rate of E-commerce (2018-2029)

    • Figure China Endometriosis Sales Volume, Sales Value and Growth Rate of Pharmacies (2018-2029)

    • Figure China Endometriosis Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Endometriosis Market Size and Growth Rate from 2018-2029

    • Figure Central China Endometriosis Market Size and Growth Rate from 2018-2029

    • Figure South China Endometriosis Market Size and Growth Rate from 2018-2029

    • Figure East China Endometriosis Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Endometriosis Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Endometriosis Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Endometriosis Market Size and Growth Rate from 2018-2029

    • Figure Endometriosis Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Endometriosis Market Share by Type in 2018

    • Figure China Endometriosis Market Share by Type in 2023

    • Figure China Endometriosis Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Endometriosis Production Volume and Growth Rate of Oral Contraceptive Pills (2018-2023)

    • Figure China Endometriosis Production Volume and Growth Rate of Gonadotropins Releasing Hormone Agonists (2018-2023)

    • Figure China Endometriosis Production Volume and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2023)

    • Figure China Endometriosis Production Volume and Growth Rate of Progestin (2018-2023)

    • Figure China Endometriosis Market Share by Application in 2018

    • Figure China Endometriosis Market Share by Application in 2023

    • Figure China Endometriosis Total Market Size and Growth Rate from Consumption End

    • Figure China Endometriosis Market Size and Growth Rate of E-commerce (2018-2023)

    • Figure China Endometriosis Market Size and Growth Rate of Pharmacies (2018-2023)

    • Figure China Endometriosis Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Endometriosis Production Volume by Region (2018-2023)

    • Table China Endometriosis Production Volume Share by Region (2018-2023)

    • Figure China Endometriosis Production Volume Share by Region (2018-2023)

    • Table China Endometriosis Production Value by Region (2018-2023)

    • Table China Endometriosis Production Value Share by Region (2018-2023)

    • Figure China Endometriosis Production Value Share by Region (2018-2023)

    • Table China Endometriosis Sales Volume by Region (2018-2023)

    • Table China Endometriosis Sales Volume Share by Region (2018-2023)

    • Figure China Endometriosis Sales Volume Share by Region (2018-2023)

    • Table China Endometriosis Sales Value by Region (2018-2023)

    • Table China Endometriosis Sales Value Share by Region (2018-2023)

    • Figure China Endometriosis Sales Value Share by Region (2018-2023)

    • Table North China Endometriosis Production Volume by Type (2018-2023)

    • Table North China Endometriosis Production Volume Share by Type (2018-2023)

    • Figure North China Endometriosis Production Volume Share by Type (2018-2023)

    • Table North China Endometriosis Sales Volume by Application (2018-2023)

    • Table North China Endometriosis Sales Volume Share by Application (2018-2023)

    • Figure North China Endometriosis Sales Volume Share by Application (2018-2023)

    • Table Central China Endometriosis Production Volume by Type (2018-2023)

    • Table Central China Endometriosis Production Volume Share by Type (2018-2023)

    • Figure Central China Endometriosis Production Volume Share by Type (2018-2023)

    • Table Central China Endometriosis Sales Volume by Application (2018-2023)

    • Table Central China Endometriosis Sales Volume Share by Application (2018-2023)

    • Figure Central China Endometriosis Sales Volume Share by Application (2018-2023)

    • Table South China Endometriosis Production Volume by Type (2018-2023)

    • Table South China Endometriosis Production Volume Share by Type (2018-2023)

    • Figure South China Endometriosis Production Volume Share by Type (2018-2023)

    • Table South China Endometriosis Sales Volume by Application (2018-2023)

    • Table South China Endometriosis Sales Volume Share by Application (2018-2023)

    • Figure South China Endometriosis Sales Volume Share by Application (2018-2023)

    • Table East China Endometriosis Production Volume by Type (2018-2023)

    • Table East China Endometriosis Production Volume Share by Type (2018-2023)

    • Figure East China Endometriosis Production Volume Share by Type (2018-2023)

    • Table East China Endometriosis Sales Volume by Application (2018-2023)

    • Table East China Endometriosis Sales Volume Share by Application (2018-2023)

    • Figure East China Endometriosis Sales Volume Share by Application (2018-2023)

    • Table Northeast China Endometriosis Production Volume by Type (2018-2023)

    • Table Northeast China Endometriosis Production Volume Share by Type (2018-2023)

    • Figure Northeast China Endometriosis Production Volume Share by Type (2018-2023)

    • Table Northeast China Endometriosis Sales Volume by Application (2018-2023)

    • Table Northeast China Endometriosis Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Endometriosis Sales Volume Share by Application (2018-2023)

    • Table Southwest China Endometriosis Production Volume by Type (2018-2023)

    • Table Southwest China Endometriosis Production Volume Share by Type (2018-2023)

    • Figure Southwest China Endometriosis Production Volume Share by Type (2018-2023)

    • Table Southwest China Endometriosis Sales Volume by Application (2018-2023)

    • Table Southwest China Endometriosis Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Endometriosis Sales Volume Share by Application (2018-2023)

    • Table Northwest China Endometriosis Production Volume by Type (2018-2023)

    • Table Northwest China Endometriosis Production Volume Share by Type (2018-2023)

    • Figure Northwest China Endometriosis Production Volume Share by Type (2018-2023)

    • Table Northwest China Endometriosis Sales Volume by Application (2018-2023)

    • Table Northwest China Endometriosis Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Endometriosis Sales Volume Share by Application (2018-2023)

    • Table Bayer HealthCare Company Profile

    • Table Bayer HealthCare Endometriosis Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Endometriosis Revenue, Price and Gross (2018-2023)

    • Table EndoCeutics Company Profile

    • Table EndoCeutics Endometriosis Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Endometriosis Revenue, Price and Gross (2018-2023)

    • Table Forendo Pharma Company Profile

    • Table Forendo Pharma Endometriosis Revenue, Price and Gross (2018-2023)

    • Table Kissei Pharmaceutical Company Profile

    • Table Kissei Pharmaceutical Endometriosis Revenue, Price and Gross (2018-2023)

    • Table Debiopharm Company Profile

    • Table Debiopharm Endometriosis Revenue, Price and Gross (2018-2023)

    • Table Addex Therapeutics Company Profile

    • Table Addex Therapeutics Endometriosis Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Endometriosis Revenue, Price and Gross (2018-2023)

    • Table Takeda Company Profile

    • Table Takeda Endometriosis Revenue, Price and Gross (2018-2023)

    • Table Euroscreen Company Profile

    • Table Euroscreen Endometriosis Revenue, Price and Gross (2018-2023)

    • Table Neurocrine Biosciences Company Profile

    • Table Neurocrine Biosciences Endometriosis Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.